Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 15 (8) , 2156-2171
Abstract
Rhabdomyosarcoma (RMS) is an aggressive pediatric soft tissue sarcoma. There are two main subtypes of RMS, alveolar rhabdomyosarcoma (ARMS) and embryonal rhabdomyosarcoma. ARMS typically encompasses fusion‐positive rhabdomyosarcoma, which expresses either PAX3‐FOXO1 or PAX7‐FOXO1 fusion proteins. There are no targeted therapies for ARMS; however, recent studies have begun to illustrate the cooperation between epigenetic proteins and the PAX3‐FOXO1 fusion, indicating that epigenetic proteins may serve as targets in ARMS. Here, we investigate the contribution of BMI1, given the established role of this epigenetic regulator in sustaining aggression in cancer. We determined that BMI1 is expressed across ARMS tumors, patient‐derived xenografts, and cell lines. We depleted BMI1 using RNAi and inhibitors (PTC‐209 and PTC‐028) and found that this leads to a decrease in cell growth/increase in apoptosis in vitro, and delays tumor growth in vivo. Our data suggest that BMI1 inhibition activates the Hippo pathway via phosphorylation of LATS1/2 and subsequent reduction in YAP levels and YAP/TAZ target genes. These results identify BMI1 as a potential therapeutic vulnerability in ARMS and warrant further investigation of BMI1 in ARMS and other sarcomas.Keywords
All Related Versions
Funding Information
- CURE Childhood Cancer
- Sarcoma Foundation of America
- National Institutes of Health (F31‐CA254301, K08‐7K08CA194162‐02, R35 CA220500, U54‐CA231630, UL1TR002378)
This publication has 64 references indexed in Scilit:
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and PitfallsFrontiers in Oncology, 2013
- Histone H2A Mono-Ubiquitination Is a Crucial Step to Mediate PRC1-Dependent Repression of Developmental Genes to Maintain ES Cell IdentityPLOS Genetics, 2012
- PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family ComplexesMolecular Cell, 2012
- Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian CancerPLOS ONE, 2011
- The Polycomb complex PRC2 and its mark in lifeNature, 2011
- BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcomaOncogene, 2010
- AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinomaOncogene, 2010
- High Expression of the PAX3-FKHR Oncoprotein Is Required to Promote Tumorigenesis of Human MyoblastsThe American Journal of Pathology, 2009
- BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent ofCDKN2ARepressionCancer Research, 2008
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958